Heights Capital Management, Inc., an investment firm based in San Francisco, submitted a major holding notification to Faron Pharmaceuticals OY on September 4, 2026. The accompanying press release was issued on Sunday.
The notification shows that Heights Capital, together with its controlled undertaking CVI Investments, Inc., now holds 46,154,796 voting rights, representing 20.25% of Faron Pharmaceuticals' total voting rights.
The stake comprises 8.95% voting rights attached to shares – 20,394,796 direct rights and 25,760,000 indirect rights – and 11.30% voting rights derived from two convertible bonds. The first bond, expiring on February 8, 2027, carries 10,080,000 voting rights (4.42%), while the second bond, expiring on February 12, 2028, carries 15,680,000 voting rights (6.88%).
Previously, Heights Capital reported a 9.41% share‑based voting right and the same 11.30% from convertible bonds, for a total of 20.72% voting rights. The controlled undertaking, CVI Investments, holds identical percentages.
Heights Capital Management is not controlled by any natural person or legal entity and does not control any other undertakings holding an interest in the issuer.
